Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1 Non-alcoholic Fatty Liver Disease 1 Neoplasm Metastasis 1 Multiple Sclerosis 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Cirrhosis, Biliary 1 Irritable Bowel Syndrome 1 Inflammatory Bowel Diseases 1 Hepatitis 1 Head and Neck Neoplasms 1 Gastritis 1 Fibrosis 1 Exocrine Pancreatic Insufficiency 1 Esthesioneuroblastoma, Olfactory 1 Dyslipidemias 1 Diabetes Mellitus 1 Cystic Fibrosis 1 Crohn Disease 1 Colorectal Adenocarcinoma 1 Colonic Neoplasms 1

Interventions

Sorafenib 68 Bevacizumab 44 Oxaliplatin 25 Doxorubicin 22 Gemcitabine 21 Fluorouracil 21 Radiosurgery 20 Nivolumab 19 durvalumab 18 Radiofrequency Ablation 18 pembrolizumab 17 lenvatinib 17 Cisplatin 17 Capecitabine 17 atezolizumab 14 Leucovorin 14 Hepatectomy 14 Radiotherapy 12 tremelimumab 10 Irinotecan 10 Drug Therapy 10 Cyclophosphamide 10 Carboplatin 10 Blood Specimen Collection 10 Ipilimumab 9 regorafenib 8 Liver Transplantation 8 Everolimus 8 Cryosurgery 8 Chemotherapy, Adjuvant 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × Phlebotomy × Gastrointestinal × Clear all

NCT02548910 2021-03-18

PRICE

Ottawa Hospital Research Institute

Phase NA Completed

62 enrolled 13 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡